These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 7553490)

  • 21. Familial prostate cancer in Sweden. A nationwide register cohort study.
    Grönberg H; Damber L; Damber JE
    Cancer; 1996 Jan; 77(1):138-43. PubMed ID: 8630920
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Early age at diagnosis in families providing evidence of linkage to the hereditary prostate cancer locus (HPC1) on chromosome 1.
    Grönberg H; Xu J; Smith JR; Carpten JD; Isaacs SD; Freije D; Bova GS; Danber JE; Bergh A; Walsh PC; Collins FS; Trent JM; Meyers DA; Isaacs WB
    Cancer Res; 1997 Nov; 57(21):4707-9. PubMed ID: 9354426
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Calculated fast-growing benign prostatic hyperplasia--a risk factor for developing clinical prostate cancer.
    Hammarsten J; Högstedt B
    Scand J Urol Nephrol; 2002; 36(5):330-8. PubMed ID: 12487736
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risk of prostate cancer for young men with a prostate specific antigen less than their age specific median.
    Loeb S; Nadler RB; Roehl KA; Antenor JA; Catalona WJ
    J Urol; 2007 May; 177(5):1745-8. PubMed ID: 17437803
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A simulation study of control sampling methods for nested case-control studies of genetic and molecular biomarkers and prostate cancer progression.
    Wang MH; Shugart YY; Cole SR; Platz EA
    Cancer Epidemiol Biomarkers Prev; 2009 Mar; 18(3):706-11. PubMed ID: 19258478
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of family history on outcomes in patients treated with definitive brachytherapy for clinically localized prostate cancer.
    Peters CA; Stock RG; Blacksburg SR; Stone NN
    Int J Radiat Oncol Biol Phys; 2009 Jan; 73(1):24-9. PubMed ID: 18692325
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Polymorphic repeats in the androgen receptor gene: molecular markers of prostate cancer risk.
    Stanford JL; Just JJ; Gibbs M; Wicklund KG; Neal CL; Blumenstein BA; Ostrander EA
    Cancer Res; 1997 Mar; 57(6):1194-8. PubMed ID: 9067292
    [TBL] [Abstract][Full Text] [Related]  

  • 28. "Just Another Statistic".
    Machtay M; Glatstein E
    Oncologist; 1998; 3(3):III-IV. PubMed ID: 10388105
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Future benefits and cost-effectiveness of prostate carcinoma screening. American Cancer Society.
    Littrup PJ
    Cancer; 1997 Nov; 80(9):1864-70. PubMed ID: 9351561
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A review of prostate-specific antigen screening prevalence and risk perceptions for first-degree relatives of men with prostate cancer.
    McDowell ME; Occhipinti S; Gardiner RA; Baade PD; Steginga SK
    Eur J Cancer Care (Engl); 2009 Nov; 18(6):545-55. PubMed ID: 19686273
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Hereditary prostate cancer].
    Nakata S; Ohtake N; Takei T; Yamanaka H
    Nihon Rinsho; 2000 Jul; 58(7):1515-8. PubMed ID: 10921334
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Could mining be protective against prostate cancer? A study and literature review.
    Girschik J; Glass D; Ambrosini GL; Fritschi L
    Occup Environ Med; 2010 Jun; 67(6):365-74. PubMed ID: 19819854
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Genetic susceptibility to prostate cancer].
    Cussenot O; Cancel-Tassin G
    Med Sci (Paris); 2004 May; 20(5):562-8. PubMed ID: 15190476
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epidemiology of prostate cancer.
    Meikle AW; Smith JA
    Urol Clin North Am; 1990 Nov; 17(4):709-18. PubMed ID: 2219573
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The evolving role of familial history for prostate cancer.
    Colloca G; Venturino A
    Acta Oncol; 2011 Jan; 50(1):14-24. PubMed ID: 20874046
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hereditary prostate cancer in Nova Scotia.
    McLellan DL; Norman RW; Bell DG
    Can J Urol; 1995 Dec; 2(4):180-4. PubMed ID: 12803707
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Age-specific risk of incident prostate cancer and risk of death from prostate cancer defined by the number of affected family members.
    Brandt A; Bermejo JL; Sundquist J; Hemminki K
    Eur Urol; 2010 Aug; 58(2):275-80. PubMed ID: 20171779
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Cancer of the prostate. 1. Epidemiology].
    Mottet Auselo N; Costa P; Le Pellec L; Louis JF; Navratil H
    Prog Urol; 1995 Feb; 5(1):31-7. PubMed ID: 7536526
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The screening of prostate cancer in 2009: overview of the oncology committee of the French Urological Association].
    Peyromaure M; Beuzeboc P; Salomon L; Richaud P; Coloby P; Malavaud B; Rebillard X; Rischmann P; Villers A; Soulie M;
    Prog Urol; 2010 Jan; 20(1):17-23. PubMed ID: 20123523
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Review of epidemiologic studies of alcohol and prostate cancer: 1971-1996.
    Breslow RA; Weed DL
    Nutr Cancer; 1998; 30(1):1-13. PubMed ID: 9507506
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.